Cancer Immunotherapy - Global Market Outlook (2020-2028)

   |      |      |  

Cancer Immunotherapy - Global Market Outlook (2020-2028)

Global Cancer Immunotherapy Market is accounted for $104.20 billion in 2020 and is expected to reach $341.63 billion by 2028 growing at a CAGR of 16.0% during the forecast period. The rise in the occurrence of cancer and the increase in adoption of immunotherapy are the factors driving the market growth. However, the high cost of treatment is hampering the growth of the market.

Cancer immunotherapy is also known as biologic therapy. It helps in cancer treatment by improving the immunity of the body to fight against cancer. In this type of therapeutic antibodies and live viruses are introduced in the body that slows the increase of cancer cells.

Based on the application, the lung cancer segment is going to have lucrative growth during the forecast period due to the increasing number of patients suffering from lung diseases. By geography, Asia Pacific is going to have high growth during the forecast period due to the presence of a large patient base in several Asian nations.

Some of the key players profiled in the Cancer Immunotherapy Market include Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb, Celgene Corporation, Eli Lily and Co., F. Hoffmann-La Roche AG , Gristone Oncology, Inc, Janssen Global Services, LLC , Merck and Co. Inc., Novartis International AG, OSE Immunotherapeutics , Printegra, and Seattle Genetics Inc.

Mode of Administrations Covered:
• Intra Vesical
• Intravenous
• Oral
• Parenteral
• Topical

Types Covered:
• Adoptive Cell Transfer
• Adopted Cell Therapies (ACT) & Indoleamine-Pyrrole 2,3-Dioxygenase (IDO) Inhibitors
• Bacillus Calmette-Guerin (BCG)
• Cancer/Treatment Vaccines
• Cell Therapies
• Cellular Immunotherapy
• Checkpoint Inhibitors/Immune Checkpoint Inhibitors
• Immuno System Modulators
• Monoclonal Antibodies (mAbs)
• Non-specific immunotherapies & Adjuvants
• Oncolytic Viral Therapies  

Applications Covered:
• Blood Cancer 
• Breast Cancer 
• Childhood Cancer 
• Colorectal Cancer 
• Head and Neck Cancer
• Liver Cancer 
• Lung Cancer 
• Melanoma 
• Multiple Myeloma 
• Non-Small Cell Lung Cancer (NSCLC) 
• Ovarian Cancer 
• Pancreatic Cancer 
• Prostate Cancer 
• Skin Cancer 
• Stomach Cancer 
• Other Applications 
    
End Users Covered:
• Ambulatory Surgical Centers
• Cancer Speciality Centers/Research Centers
• Diagnostic Centers
• Homecare
• Hospitals & Clinics
• Households & Personalcare
• Medical Use
• Printing Inks 

Distribution Channels Covered:
• Online Pharmacy
• Offline Pharmacy   

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

 

1 Executive Summary     
      
2 Preface     
 2.1 Abstract    
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology    
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions   
      
3 Market Trend Analysis     
 3.1 Introduction    
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats    
 3.6 Application Analysis    
 3.7 End User Analysis    
 3.8 Emerging Markets    
 3.9 Impact of Covid-19    
      
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry    
      
5 Global Cancer Immunotherapy Market, By Mode of Administration     
 5.1 Introduction    
 5.2 Intra Vesical    
 5.3 Intravenous    
 5.4 Oral    
 5.5 Parenteral    
 5.6 Topical    
      
6 Global Cancer Immunotherapy Market, By Type     
 6.1 Introduction    
 6.2 Adoptive Cell Transfer    
 6.3 Adopted Cell Therapies (ACT) & Indoleamine-Pyrrole 2,3-Dioxygenase (IDO) Inhibitors    
 6.4 Bacillus Calmette-Guerin (BCG)    
 6.5 Cancer/Treatment Vaccines    
  6.5.1 Prophylactic Vaccines   
  6.5.2 Therapeutic Vaccines   
 6.6 Cell Therapies    
  6.6.1 Chimeric Antigen Receptor (CAR) T Cell Therapy   
  6.6.2 Dendritic Cells   
 6.7 Cellular Immunotherapy    
 6.8 Checkpoint Inhibitor/Immune Checkpoint Inhibitors    
  6.8.1 Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4)   
  6.8.2 Programmed Death 1 (PD-1) & Programmed Death Ligand 1 (PD-L1)   
  6.8.3 Tumor-Infiltrating Lymphocytes (TILs) and Interleukin-2 (IL-2)   
 6.9 Immuno System Modulators    
  6.9.1 Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF & G-CSF)   
  6.9.2 Interleukins (IL)   
  6.9.3 Interferons (IFN)   
  6.9.4 Oncolytic Virus   
   6.9.4.1 Approved Products & Clinical Trails  
   6.9.4.2 Immunity as an Ally  
   6.9.4.3 Immunity as an Obstacle  
   6.9.4.4 Immunotherapy  
 6.10 Monoclonal Antibodies (mAbs)    
  6.10.1 Bispecific Monoclonal Antibodies   
  6.10.2 Conjugated Monoclonal Antibodies   
  6.10.3 Naked Monoclonal Antibodies   
 6.11 Non-specific Immunotherapies & Adjuvants    
  6.11.1 Cytokines   
 6.12 Oncolytic Viral Therapies    
      
7 Global Cancer Immunotherapy Market, By Application     
 7.1 Introduction    
 7.2 Blood Cancer    
 7.3 Breast Cancer    
 7.4 Childhood Cancer    
 7.5 Colorectal Cancer    
 7.6 Head and Neck Cancer    
 7.7 Liver Cancer    
 7.8 Lung Cancer    
 7.9 Melanoma    
 7.10 Multiple Myeloma    
 7.11 Non-Small Cell Lung Cancer (NSCLC)    
 7.12 Ovarian Cancer    
 7.13 Pancreatic Cancer    
 7.14 Prostate Cancer    
 7.15 Skin Cancer    
 7.16 Stomach Cancer    
 7.17 Other Applications    
  7.17.1 Cervical   
  7.17.2 Gastric   
  7.17.3 Lymphoma   
  7.17.4 Renal Cell Carcinoma   
      
8 Global Cancer Immunotherapy Market, By End User     
 8.1 Introduction    
 8.2 Ambulatory Surgical Centers    
 8.3 Cancer Speciality Centers/Research Centers    
 8.4 Diagnostic Centers    
 8.5 Homecare    
 8.6 Hospitals & Clinics    
 8.7 Households & Personalcare    
 8.8 Medical Use    
 8.9 Printing Inks    
      
9 Global Cancer Immunotherapy Market, By Distribution Channel     
 9.1 Introduction    
 9.2 Online Pharmacy    
 9.3 Offline Pharmacy    
  9.3.1 Hospital Pharmacy   
  9.3.2 Retail Pharmacy   
      
10 Global Cancer Immunotherapy Market, By Geography     
 10.1 Introduction    
 10.2 North America    
  10.2.1 US   
  10.2.2 Canada   
  10.2.3 Mexico   
 10.3 Europe    
  10.3.1 Germany   
  10.3.2 UK   
  10.3.3 Italy   
  10.3.4 France   
  10.3.5 Spain   
  10.3.6 Rest of Europe   
 10.4 Asia Pacific    
  10.4.1 Japan   
  10.4.2 China   
  10.4.3 India   
  10.4.4 Australia   
  10.4.5 New Zealand   
  10.4.6 South Korea   
  10.4.7 Rest of Asia Pacific   
 10.5 South America    
  10.5.1 Argentina   
  10.5.2 Brazil   
  10.5.3 Chile   
  10.5.4 Rest of South America   
 10.6 Middle East & Africa    
  10.6.1 Saudi Arabia   
  10.6.2 UAE   
  10.6.3 Qatar   
  10.6.4 South Africa   
  10.6.5 Rest of Middle East & Africa   
      
11 Key Developments     
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 11.2 Acquisitions & Mergers    
 11.3 New Product Launch    
 11.4 Expansions    
 11.5 Other Key Strategies    
      
12 Company Profiling     
 12.1 Amgen Inc.    
 12.2 Astellas Pharma Inc.    
 12.3 AstraZeneca plc    
 12.4 Bayer AG    
 12.5 Bristol-Myers Squibb    
 12.6 Celgene Corporation    
 12.7 Eli Lily and Co.    
 12.8 F. Hoffmann-La Roche AG    
 12.9 Gristone Oncology, Inc    
 12.10 Janssen Global Services, LLC    
 12.11 Merck and Co. Inc.    
 12.12 Novartis International AG    
 12.13 OSE Immunotherapeutics    
 12.14 Printegra    
 12.15 Seattle Genetics Inc    

 

 

Cancer Immunotherapy - Global Market Outlook (2020-2028)

List of Tables      
1 Global Cancer Immunotherapy Market Outlook, By Region (2019-2028) (US $MN)      
2 Global Cancer Immunotherapy Market Outlook, By Mode of Administration  (2019-2028) (US $MN)      
3 Global Cancer Immunotherapy Market Outlook, By Intra Vesical (2019-2028) (US $MN)      
4 Global Cancer Immunotherapy Market Outlook, By Intravenous (2019-2028) (US $MN)      
5 Global Cancer Immunotherapy Market Outlook, By Oral (2019-2028) (US $MN)      
6 Global Cancer Immunotherapy Market Outlook, By Parenteral (2019-2028) (US $MN)      
7 Global Cancer Immunotherapy Market Outlook, By Topical (2019-2028) (US $MN)      
8 Global Cancer Immunotherapy Market Outlook, By Type (2019-2028) (US $MN)      
9 Global Cancer Immunotherapy Market Outlook, By Adoptive Cell Transfer (2019-2028) (US $MN)      
10 Global Cancer Immunotherapy Market Outlook, By Adopted Cell Therapies (ACT) & Indoleamine-Pyrrole 2,3-Dioxygenase (IDO) Inhibitors (2019-2028) (US $MN)      
11 Global Cancer Immunotherapy Market Outlook, By Bacillus Calmette-Guerin (BCG) (2019-2028) (US $MN)      
12 Global Cancer Immunotherapy Market Outlook, By Cancer/Treatment Vaccines (2019-2028) (US $MN)      
13 Global Cancer Immunotherapy Market Outlook, By Prophylactic Vaccines (2019-2028) (US $MN)      
14 Global Cancer Immunotherapy Market Outlook, By Therapeutic Vaccines (2019-2028) (US $MN)      
15 Global Cancer Immunotherapy Market Outlook, By Cell Therapies (2019-2028) (US $MN)      
16 Global Cancer Immunotherapy Market Outlook, By Chimeric Antigen Receptor (CAR) T Cell Therapy (2019-2028) (US $MN)      
17 Global Cancer Immunotherapy Market Outlook, By Dendritic Cells (2019-2028) (US $MN)      
18 Global Cancer Immunotherapy Market Outlook, By Cellular Immunotherapy (2019-2028) (US $MN)      
19 Global Cancer Immunotherapy Market Outlook, By Checkpoint Inhibitor/Immune Checkpoint Inhibitors (2019-2028) (US $MN)      
20 Global Cancer Immunotherapy Market Outlook, By Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4) (2019-2028) (US $MN)      
21 Global Cancer Immunotherapy Market Outlook, By Programmed Death 1 (PD-1) & Programmed Death Ligand 1 (PD-L1) (2019-2028) (US $MN)      
22 Global Cancer Immunotherapy Market Outlook, By Tumor-Infiltrating Lymphocytes (TILs) and Interleukin-2 (IL-2) (2019-2028) (US $MN)      
23 Global Cancer Immunotherapy Market Outlook, By Immuno System Modulators (2019-2028) (US $MN)       
24 Global Cancer Immunotherapy Market Outlook, By Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF & G-CSF) (2019-2028) (US $MN)      
25 Global Cancer Immunotherapy Market Outlook, By Interleukins (IL) (2019-2028) (US $MN)      
26 Global Cancer Immunotherapy Market Outlook, By Interferons (IFN) (2019-2028) (US $MN)      
27 Global Cancer Immunotherapy Market Outlook, By Oncolytic Virus (2019-2028) (US $MN)      
28 Global Cancer Immunotherapy Market Outlook, By Monoclonal Antibodies (mAbs) (2019-2028) (US $MN)      
29 Global Cancer Immunotherapy Market Outlook, By Bispecific Monoclonal Antibodies (2019-2028) (US $MN)      
30 Global Cancer Immunotherapy Market Outlook, By Conjugated Monoclonal Antibodies (2019-2028) (US $MN)      
31 Global Cancer Immunotherapy Market Outlook, By Naked Monoclonal Antibodies (2019-2028) (US $MN)      
32 Global Cancer Immunotherapy Market Outlook, By Non-specific Immunotherapies & Adjuvants (2019-2028) (US $MN)      
33 Global Cancer Immunotherapy Market Outlook, By Cytokines (2019-2028) (US $MN)      
34 Global Cancer Immunotherapy Market Outlook, By Oncolytic Viral Therapies (2019-2028) (US $MN)      
35 Global Cancer Immunotherapy Market Outlook, By Application (2019-2028) (US $MN)      
36 Global Cancer Immunotherapy Market Outlook, By Blood Cancer (2019-2028) (US $MN)      
37 Global Cancer Immunotherapy Market Outlook, By Breast Cancer (2019-2028) (US $MN)      
38 Global Cancer Immunotherapy Market Outlook, By Childhood Cancer (2019-2028) (US $MN)      
39 Global Cancer Immunotherapy Market Outlook, By Colorectal Cancer (2019-2028) (US $MN)      
40 Global Cancer Immunotherapy Market Outlook, By Head and Neck Cancer (2019-2028) (US $MN)      
41 Global Cancer Immunotherapy Market Outlook, By Liver Cancer (2019-2028) (US $MN)      
42 Global Cancer Immunotherapy Market Outlook, By Lung Cancer (2019-2028) (US $MN)      
43 Global Cancer Immunotherapy Market Outlook, By Melanoma (2019-2028) (US $MN)      
44 Global Cancer Immunotherapy Market Outlook, By Multiple Myeloma (2019-2028) (US $MN)      
45 Global Cancer Immunotherapy Market Outlook, By Non-Small Cell Lung Cancer (NSCLC) (2019-2028) (US $MN)      
46 Global Cancer Immunotherapy Market Outlook, By Ovarian Cancer (2019-2028) (US $MN)       
47 Global Cancer Immunotherapy Market Outlook, By Pancreatic Cancer (2019-2028) (US $MN)      
48 Global Cancer Immunotherapy Market Outlook, By Prostate Cancer (2019-2028) (US $MN)      
49 Global Cancer Immunotherapy Market Outlook, By Skin Cancer (2019-2028) (US $MN)      
50 Global Cancer Immunotherapy Market Outlook, By Stomach Cancer (2019-2028) (US $MN)      
51 Global Cancer Immunotherapy Market Outlook, By Other Applications (2019-2028) (US $MN)      
52 Global Cancer Immunotherapy Market Outlook, By Cervical (2019-2028) (US $MN)      
53 Global Cancer Immunotherapy Market Outlook, By Gastric (2019-2028) (US $MN)      
54 Global Cancer Immunotherapy Market Outlook, By Lymphoma (2019-2028) (US $MN)      
55 Global Cancer Immunotherapy Market Outlook, By Renal Cell Carcinoma (2019-2028) (US $MN)      
56 Global Cancer Immunotherapy Market Outlook, By End User (2019-2028) (US $MN)      
57 Global Cancer Immunotherapy Market Outlook, By Ambulatory Surgical Centers (2019-2028) (US $MN)       
58 Global Cancer Immunotherapy Market Outlook, By Cancer Speciality Centers/Research Centers (2019-2028) (US $MN)      
59 Global Cancer Immunotherapy Market Outlook, By Diagnostic Centers (2019-2028) (US $MN)      
60 Global Cancer Immunotherapy Market Outlook, By Homecare (2019-2028) (US $MN)      
61 Global Cancer Immunotherapy Market Outlook, By Hospitals & Clinics (2019-2028) (US $MN)      
62 Global Cancer Immunotherapy Market Outlook, By Households & Personalcare (2019-2028) (US $MN)      
63 Global Cancer Immunotherapy Market Outlook, By Medical Use (2019-2028) (US $MN)      
64 Global Cancer Immunotherapy Market Outlook, By Printing Inks (2019-2028) (US $MN)      
65 Global Cancer Immunotherapy Market Outlook, By Distribution Channel (2019-2028) (US $MN)      
66 Global Cancer Immunotherapy Market Outlook, By Online Pharmacy (2019-2028) (US $MN)      

.